Boston, United States
Eascra Biotech is a biotechnology startup based in the United States, founded in 2022. The company's slogan "Building the next generation of innovative therapeutic nanotechnologies" encapsulates its commitment to leveraging DNA nanotechnology to develop novel Janus base nanomaterials. These nanomaterials offer enhanced therapeutic delivery and regenerative medicine for chronic conditions such as articular cartilage degeneration, central nervous system disorders, and solid tumors.
Eascra Biotech's three generations of DNA-inspired nanotubes present a cost-effective and scalable alternative to existing solutions, making them a promising avenue for innovation in Biotechnology and Health Care industries. The company's ability to customize its Janus base nanotechnologies further underscores its potential to enhance the efficacy of drug treatments for a wide range of medical needs.
While the exact details of the company's funding history are not available, Eascra Biotech's focus on cutting-edge nanotechnologies and therapeutic solutions could be of interest to venture capital firms seeking opportunities in the biotechnology and health care sectors.
